Douglas H. Thamm - Publications, H-index & Citations

Douglas H. Thamm

Colorado State University System

57H指数

301论文数

1.1W被引数

收录论文 54

发表时间

Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know 兽医肿瘤学基因组学诊断中的关键问题：我们需要了解什么

Veterinary and Comparative Oncology

IF1.9

2026-09-01

PREAI

Sakthikumar, Sharadha; Siravegna, Giulia; White, Michelle E.; Thamm, Douglas H.; Chon, Esther

Bortezomib Pharmacokinetics and In Vitro Pharmacokinetic/Pharmacodynamic Analysis to Support Canine Clinical Studies in Osteosarcoma 硼替佐米药代动力学及体外药代动力学/药效学分析以支持犬骨肉瘤临床研究

Journal of Pharmacology and Experimental Therapeutics

IF3.8

2026-05-01

PREAI

Gustafson, Daniel; Early, Kala; Banks, Krista; Benedict, William; Thamm, Douglas H.

Distinct tumor genomic signatures underlie canine macrophage polarization 犬巨噬细胞极化的不同肿瘤基因组特征

PLoS One

IF2.6

2026-04-24

PREAI

Brady, Rachel V.; Das, Sunetra; Duval, Dawn L.; Farrell, Kristen B.; Palmer, Eric P.; Thamm, Douglas H.

Comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas 比较基因组学和临床病理学分析揭示了犬类与人类甲状腺癌的分子谱对比特征

Communications Biology

IF5.1

2025-12-06

OAAI

Sunetra Das; Samantha N. Schlemmer; Rupa Idate; Susan E. Lana; Daniel P. Regan; Douglas H. Thamm; Dawn L. Duval

Vaccination Against Extracellular Vimentin Plus Doxorubicin for Canine Hemangiosarcoma 针对犬血管肉瘤的细胞外波形蛋白疫苗接种联合多柔比星治疗方案

International Journal of Molecular Sciences 2025, Vol. 26, Page 9096

IF4.9

2025-09-21

OAAI

Diederik J. M. Engbersen; Lobke van Bergen; Emma N. Bos; Quinty Hansen; Arno Roos; Elisabeth J. M. Huijbers; Erica A. Faulhaber; Pancras C. W. Hogendoorn; Douglas H. Thamm; Arjan W. Griffioen

PI3K-AKT-mTOR dual inhibitor, VDC597, as a therapeutic agent for canine osteosarcoma PI3K-AKT-mTOR双抑制剂VDC597作为犬骨肉瘤的治疗药物

The Journal of Pharmacology and Experimental Therapeutics

IF0

2025-09-17

PREAI

Travis Meuten; Kristen B. Farrell; Barbara J. Rose; Samuel A. Brill; Rachel V. Brady; Lisa J. Schlein; Douglas H. Thamm

Clinical, pathological and prognostic features of surgically excised cutaneous and subcutaneous digital and distal limb mast cell tumours in dogs 犬手术切除的皮肤及皮下指（趾）部与远端肢体肥大细胞瘤的临床、病理及预后特征

JOURNAL OF SMALL ANIMAL PRACTICE

IF1.9

2025-09-01

OAAI

Erickson, A. K.; Tremolada, G.; Sztukowski, K. E.; Thamm, D. H.; Husbands, B. D.

Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs

MOLECULES

IF4.6

2025-01-16

OAAI

Klawitter, Jost; Easton, Mckay; Karpeisky, Alexander; Farrell, Kristen B.; Thamm, Douglas H.; Shokati, Touraj; Christians, Uwe; Zinnen, Shawn Patrick

Parthenolide As a Therapeutic for Disseminated Canine Neoplasms

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-03-01

OAAI

Schlein, Lisa J.; Brill, Samuel A.; Brady, Rachel V.; Farrell, Kristen B.; Rose, Barbara J.; Meuten, Travis K.; Jordan, Craig T.; Thamm, Douglas H.

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs 肿瘤相关巨噬细胞: 人类和狗癌症的预后和治疗靶点

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-04-05

OAAI

Brady, Rachel V.; Thamm, Douglas H.

Omacetaxine reduces c-MYC expression and demonstrates antitumor effects in osteosarcoma

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Farrell, Kristen B.; Thamm, Douglas H.

Evaluation of tumor draining lymph nodes in dogs with spontaneously arising osteosarcoma using single-cell sequencing

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Brill, Samuel A.; Ammons, Dylan T.; Avery, Anne C.; Thamm, Douglas H.

Gemcitabine-Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with Docetaxel

BIOCONJUGATE CHEMISTRY

IF3.9

2021-11-15

OAAI

Farrell, Kristen B.; Zinnen, Shawn; Thamm, Douglas H.; Karpeisky, Alexander

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma

COMMUNICATIONS BIOLOGY

IF5.1

2021-10-11

OAAI

Das, Sunetra; Idate, Rupa; Regan, Daniel P.; Fowles, Jared S.; Lana, Susan E.; Thamm, Douglas H.; Gustafson, Daniel L.; Duval, Dawn L.

Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment

LAB ON A CHIP

IF5.4

2021-01-01

PREAI

Smith, Kaylee Judith; Jana, Jessica Antoinette; Kaehr, Anna; Purcell, Emma; Opdycke, Tyler; Paoletti, Costanza; Cooling, Laura; Thamm, Douglas H.; Hayes, Daniel F.; Nagrath, Sunitha

A comparative oncology approach to biomarker and drug discovery for cancer diagnosis and treatment in dogs and humans

CANCER RESEARCH

IF16.6

2020-08-15

PREAI

LeBlanc, Amy Kathleen; Mazcko, Christina N.; Breen, Matthew; Thomas, Rachael; Thamm, Douglas H.

Canine Cancer: Strategies in Experimental Therapeutics

FRONTIERS IN ONCOLOGY

IF3.3

2019-11-15

OAAI

Thamm, Douglas H.

Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs 从荷瘤犬中分离出的多形核髓源性抑制细胞的细菌杀伤活性

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-10-10

OAAI

Hlavaty, Sabina I.; Chang, Yu-Mei; Orth, Rachel P.; Goulian, Mark; Planet, Paul J.; Thamm, Douglas H.; Punt, Jennifer A.; Garden, Oliver A.

CPI-818: A selective inhibitor of interleukin-2-inducible T-cell kinase (ITK) that inhibits T-cell receptor signaling, promotes Th1 skewing, and achieves objective tumor responses when administered to dogs with T cell lymphomas

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Janc, James W.; Hill, Craig M.; Ng, Patrick P.; Hoston, Andrew N.; Madriaga, Antonett; Dao-Pick, Trang P.; Yeung, Kitman S.; Hudson, Ryan; Beausoleil, Anne-Marie; Bradley, Erin; Verner, Erik; Thamm, Douglas H.; Miller, Richard A.; Buggy, Joseph J.

Continuous, high throughput microfluidic device to monitor circulating tumor cells in cancer patients

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Smith, Kaylee; Kim, Tae Hyun; Paoletti, Costanza; Thamm, Douglas H.; Hayes, Daniel F.; Nagrath, Sunitha

研究方向